137 related articles for article (PubMed ID: 14718356)
1. Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function.
Summar ML; Gainer JV; Pretorius M; Malave H; Harris S; Hall LD; Weisberg A; Vaughan DE; Christman BW; Brown NJ
Hypertension; 2004 Feb; 43(2):186-91. PubMed ID: 14718356
[TBL] [Abstract][Full Text] [Related]
2. Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.
Pearson DL; Dawling S; Walsh WF; Haines JL; Christman BW; Bazyk A; Scott N; Summar ML
N Engl J Med; 2001 Jun; 344(24):1832-8. PubMed ID: 11407344
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Giannarelli C; De Negri F; Virdis A; Ghiadoni L; Cipriano A; Magagna A; Taddei S; Salvetti A
Hypertension; 2007 Apr; 49(4):878-84. PubMed ID: 17339540
[TBL] [Abstract][Full Text] [Related]
4. Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men.
Nietlispach F; Julius B; Schindler R; Bernheim A; Binkert C; Kiowski W; Brunner-La Rocca HP
Hypertension; 2007 Jul; 50(1):82-8. PubMed ID: 17502494
[TBL] [Abstract][Full Text] [Related]
5. The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes.
Wotherspoon F; Browne DL; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
Diabet Med; 2005 Jun; 22(6):697-702. PubMed ID: 15910619
[TBL] [Abstract][Full Text] [Related]
6. Direct biochemical evidence for eNOS stimulation by bradykinin in the human forearm vasculature.
Lauer T; Kleinbongard P; Preik M; Rauch BH; Deussen A; Feelisch M; Strauer BE; Kelm M
Basic Res Cardiol; 2003 Mar; 98(2):84-9. PubMed ID: 12607129
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin type 2 receptor BE1 genotype influences bradykinin-dependent vasodilation during angiotensin-converting enzyme inhibition.
Van Guilder GP; Pretorius M; Luther JM; Byrd JB; Hill K; Gainer JV; Brown NJ
Hypertension; 2008 Feb; 51(2):454-9. PubMed ID: 18180402
[TBL] [Abstract][Full Text] [Related]
8. Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole.
Passauer J; Büssemaker E; Lässig G; Pistrosch F; Fauler J; Gross P; Fleming I
Clin Sci (Lond); 2003 Oct; 105(4):513-8. PubMed ID: 12826020
[TBL] [Abstract][Full Text] [Related]
9. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
10. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus.
Williams SB; Cusco JA; Roddy MA; Johnstone MT; Creager MA
J Am Coll Cardiol; 1996 Mar; 27(3):567-74. PubMed ID: 8606266
[TBL] [Abstract][Full Text] [Related]
11. The C242T p22phox polymorphism and endothelium-dependent vasodilation in subjects with hypercholesterolaemia.
Schneider MP; Hilgers KF; Huang Y; Delles C; John S; Oehmer S; Schmieder RE
Clin Sci (Lond); 2003 Jul; 105(1):97-103. PubMed ID: 12639216
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro evidence for ACh-stimulated L-arginine uptake.
Parnell MM; Chin-Dusting JP; Starr J; Kaye DM
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H395-400. PubMed ID: 15016636
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia.
Green D; O'Driscoll G; Rankin JM; Maiorana AJ; Taylor RR
Clin Sci (Lond); 1998 Sep; 95(3):361-7. PubMed ID: 9730857
[TBL] [Abstract][Full Text] [Related]
14. The T1405N carbamoyl phosphate synthetase polymorphism does not affect plasma arginine concentrations in preterm infants.
Moonen RM; Reyes I; Cavallaro G; González-Luis G; Bakker JA; Villamor E
PLoS One; 2010 May; 5(5):e10792. PubMed ID: 20520828
[TBL] [Abstract][Full Text] [Related]
15. Carbamoyl phosphate synthetase polymorphisms as a risk factor for necrotizing enterocolitis.
Moonen RM; Paulussen AD; Souren NY; Kessels AG; Rubio-Gozalbo ME; Villamor E
Pediatr Res; 2007 Aug; 62(2):188-90. PubMed ID: 17597649
[TBL] [Abstract][Full Text] [Related]
16. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide.
Passauer J; Pistrosch F; Büssemaker E; Lässig G; Herbrig K; Gross P
J Am Soc Nephrol; 2005 Apr; 16(4):959-65. PubMed ID: 15728785
[TBL] [Abstract][Full Text] [Related]
17. Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans.
Haefeli WE; Linder L; Lüscher TF
Hypertension; 1997 Oct; 30(4):912-7. PubMed ID: 9336392
[TBL] [Abstract][Full Text] [Related]
18. Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo.
Seddon MD; Chowienczyk PJ; Brett SE; Casadei B; Shah AM
Circulation; 2008 Apr; 117(15):1991-6. PubMed ID: 18391107
[TBL] [Abstract][Full Text] [Related]
19. Selective impairment of nitric oxide dependent vasodilation in young adults with hypercholesterolaemia.
Preik M; Kelm M; Schoebel F; Schottenfeld Y; Leschke M; Strauer BE
J Cardiovasc Risk; 1996 Oct; 3(5):465-71. PubMed ID: 9048263
[TBL] [Abstract][Full Text] [Related]
20. Role of endothelium-derived hyperpolarizing factor in human forearm circulation.
Inokuchi K; Hirooka Y; Shimokawa H; Sakai K; Kishi T; Ito K; Kimura Y; Takeshita A
Hypertension; 2003 Nov; 42(5):919-24. PubMed ID: 14557280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
